Market Trends of UAE Endoscopy Devices Industry
This section covers the major market trends shaping the UAE Endoscopy Devices Market according to our research experts:
The Urology Segment is Expected to Hold the Largest Share in the UAE Endoscopy Equipment Market During the Forecast Period
Urological disorders are becoming more common in the United Arab Emirates. Additionally, the growing prevalence of urinary diseases and the increased number of ureteroscopic interventions performed in the United Arab Emirates are expected to increase the demand for endoscopic equipment, thereby driving the growth of the studied segment.
An article published in Krager in March 2021 revealed a pooled incidence rate of 2.33 per 100,000 persons per year for ulcerative colitis in the Arab world. Similarly, the UAE's pooled incidence rate for Crohn's disease was 1.46 per 100,000 people per year.Thus, there is a growing incidence of inflammatory bowel diseases in the UAE, which is expected to contribute to the growing demand for endoscopy devices, thereby contributing to the growth of the studied segment. Additionally, the Omnia Health article published in July 2021 mentioned that 3%-5% of the UAE population is affected by chronic kidney disease. The prevalence of various urological disorders is expected to drive demand for effective endoscopy procedures, contributing to the segment's growth over the forecast period.
The market is also being driven by the introduction of advanced endoscopic techniques in urology, such as robot-assisted endoscopes and disposable endoscopes.
Gastroenterology is Expected to Hold Notable Share in the Market Over the Forecast Period
Gastroenterology endoscopy diagnoses the diseases prevalent in the digestive systems, such as the esophagus, stomach, intestines, liver, biliary tract, and pancreas. The rising demand for endoscopy procedures and increasing market player activities such as collaborations, partnerships, and managers to develop gastroenterology endoscopy procedures are expected to be the major factors driving the growth of the market. For instance, in September 2021, the gastroenterology team at Abu Dhabi-based Sheikh Shakhbout Medical City (SSMC), a joint-venture partnership between Mayo Clinic and Abu Dhabi Health Services Company (SEHA), introduced a cutting-edge AI system (an FDA- and UAE-approved system), GI Genius. It is an AI solution designed to assist in colonoscopy procedures.
Also, in July 2021, Scope Investment, located in the United Arab Emirates, partnered with Asan Medical Center (AMC) to open the GCC's first complete GI (gastroenterology) hospital in the United Arab Emirates. The partnership is expected to bring standards of specialized healthcare in the fields of digestive health and oncology to the UAE. Such rising investments and partnerships among various market players are expected to contribute to the growth of the studied segment in the UAE.
